| C095284 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one | "1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Mevinphos results in increased expression of PRKG1 protein]" | 15617736 |
| C459092 | 2-methyl-1-((4-methyl-5-isoquinolinyl)sulfonyl)homopiperazine | "2-methyl-1-((4-methyl-5-isoquinolinyl)sulfonyl)homopiperazine inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of ARHGEF17 protein]" | 23195829 |
| C459092 | 2-methyl-1-((4-methyl-5-isoquinolinyl)sulfonyl)homopiperazine | "[calyculin A co-treated with Okadaic Acid] inhibits the reaction [2-methyl-1-((4-methyl-5-isoquinolinyl)sulfonyl)homopiperazine inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of ARHGEF17 protein]]" | 23195829 |
| C090937 | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole | 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole results in increased expression of PRKG1 protein | 11602670 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKG1 mRNA" | 27188386 |
| C439285 | (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride | (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride results in increased expression of PRKG1 protein | 11602670 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKG1 mRNA" | 27188386 |
| C080122 | 7-nitroindazole | 7-nitroindazole inhibits the reaction [Mevinphos results in increased expression of PRKG1 protein] | 15617736 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | "2-methyl-1-((4-methyl-5-isoquinolinyl)sulfonyl)homopiperazine inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of ARHGEF17 protein]" | 23195829 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | "[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein co-treated with ARHGEF17 protein] results in increased activity of SRF protein" | 23195829 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | "[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] promotes the reaction [ARHGEF17 protein results in increased activity of RHOA protein]" | 23195829 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | "[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of ARHGEF17 protein" | 23195829 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | "[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of RHOA protein" | 23195829 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | "8-((4-chlorophenyl)thio)cyclic-3',5'-GMP promotes the reaction [PRKG1 protein binds to and results in increased phosphorylation of ARHGEF17 protein]" | 23195829 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | "[calyculin A co-treated with Okadaic Acid] inhibits the reaction [2-methyl-1-((4-methyl-5-isoquinolinyl)sulfonyl)homopiperazine inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of ARHGEF17 protein]]" | 23195829 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | "KT 5823 inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of RHOA protein]" | 23195829 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | "KT 5823 inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-GMP promotes the reaction [PRKG1 protein binds to and results in increased phosphorylation of ARHGEF17 protein]]" | 23195829 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | "Y 27632 inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of ARHGEF17 protein]" | 23195829 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | "[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]" | 11799084 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | "8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in decreased expression of PRKG1 protein" | 9366573 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | "8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in decreased expression of PRKG1 protein alternative form" | 11799084 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | "8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in increased activity of PRKG1 protein" | 11799084 |
| C090860 | 8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate | "PRKG1 protein affects the reaction [8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate results in decreased expression of IL4 protein]" | 16533816 |
| C090860 | 8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate | "8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate binds to and results in decreased activity of PRKG1 protein" | 19542178 |
| C016276 | 8-bromocyclic GMP | [8-bromocyclic GMP co-treated with PRKG1 protein co-treated with ARHGEF17 protein] results in increased activity of SRF protein | 23195829 |
| C016276 | 8-bromocyclic GMP | 8-bromocyclic GMP results in increased activity of PRKG1 protein | 17616649 |
| C016276 | 8-bromocyclic GMP | Acetylcysteine inhibits the reaction [Oxygen deficiency inhibits the reaction [8-bromocyclic GMP results in increased activity of PRKG1 protein]] | 17616649 |
| C016276 | 8-bromocyclic GMP | Oxygen deficiency inhibits the reaction [8-bromocyclic GMP results in increased activity of PRKG1 protein] | 17616649 |
| C016276 | 8-bromocyclic GMP | 8-bromocyclic GMP results in increased expression of PRKG1 protein | 12620371 |
| C016276 | 8-bromocyclic GMP | 8-bromocyclic GMP results in increased activity of PRKG1 protein | 12620371|1935937 |
| C083763 | 8-bromoguanosino-3',5'-cyclic monophosphorothioate | "8-bromoguanosino-3',5'-cyclic monophosphorothioate inhibits the reaction [Formaldehyde results in increased expression of PRKG1 protein]" | 12620371 |
| C083763 | 8-bromoguanosino-3',5'-cyclic monophosphorothioate | "8-bromoguanosino-3',5'-cyclic monophosphorothioate analog results in decreased activity of PRKG1 protein" | 12620371 |
| C083763 | 8-bromoguanosino-3',5'-cyclic monophosphorothioate | "8-bromoguanosino-3',5'-cyclic monophosphorothioate results in decreased activity of PRKG1 protein" | 12620371 |
| C056165 | acetovanillone | acetovanillone inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | 17320767 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Oxygen deficiency inhibits the reaction [8-bromocyclic GMP results in increased activity of PRKG1 protein]] | 17616649 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Oxygen deficiency results in decreased expression of PRKG1 protein] | 17616649 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of PRKG1 mRNA | 22100608 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of PRKG1 gene | 27153756 |
| D000535 | Aluminum | [APP protein modified form binds to Aluminum] which results in increased expression of PRKG1 mRNA | 21298039 |
| D000641 | Ammonia | PRKG1 protein affects the susceptibility to Ammonia | 19393034 |
| C015001 | arsenite | [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of PRKG1 mRNA | 15894712 |
| C015001 | arsenite | arsenite results in decreased expression of PRKG1 mRNA | 15894712 |
| D001280 | Atrazine | Atrazine results in decreased expression of PRKG1 mRNA | 25929836 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of PRKG1 mRNA | 22316170 |
| D001564 | Benzo(a)pyrene | [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of PRKG1 mRNA | 15894712 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of PRKG1 mRNA | 15894712 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PRKG1 mRNA" | 20382639 |
| C543008 | bis(4-hydroxyphenyl)sulfone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PRKG1 mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A results in increased expression of PRKG1 mRNA | 29275510 |
| C006780 | bisphenol A | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRKG1 mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of PRKG1 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of PRKG1 gene | 28505145 |
| C000611646 | bisphenol F | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRKG1 mRNA | 28628672 |
| D002118 | Calcium | PRKG1 protein results in increased susceptibility to Calcium | 16533816 |
| C059041 | calyculin A | "[calyculin A co-treated with Okadaic Acid] inhibits the reaction [2-methyl-1-((4-methyl-5-isoquinolinyl)sulfonyl)homopiperazine inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of ARHGEF17 protein]]" | 23195829 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride affects the expression of PRKG1 mRNA | 17484886 |
| D003300 | Copper | [Phenylephrine co-treated with Copper] results in increased activity of PRKG1 protein | 26168186 |
| D003300 | Copper | VIM mutant form inhibits the reaction [[Copper co-treated with Phenylephrine] results in increased activity of PRKG1 protein] | 26168186 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of PRKG1 mRNA | 16378109 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of PRKG1 protein | 16378109 |
| D016572 | Cyclosporine | Phenylephrine inhibits the reaction [Cyclosporine results in increased expression of PRKG1 mRNA] | 16378109 |
| D016572 | Cyclosporine | Phenylephrine inhibits the reaction [Cyclosporine results in increased expression of PRKG1 protein] | 16378109 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PRKG1 mRNA | 28628672 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRKG1 mRNA | 28628672 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRKG1 mRNA | 28628672 |
| D003994 | Bucladesine | Bucladesine results in decreased expression of PRKG1 mRNA | 9366573 |
| C036042 | dicyclohexyl phthalate | dicyclohexyl phthalate affects the expression of PRKG1 mRNA | 26924002 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of PRKG1 mRNA | 18042831 |
| C058705 | diethyl malate | diethyl malate affects the expression of PRKG1 mRNA | 24814887 |
| C024629 | dimethyl phthalate | dimethyl phthalate results in decreased expression of PRKG1 mRNA | 26924002 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | 17320767 |
| D004610 | Ellagic Acid | Ellagic Acid results in decreased expression of PRKG1 mRNA | 12002526 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of PRKG1 mRNA | 17555576 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of PRKG1 mRNA | 17942748 |
| D005473 | Fluoxetine | Fluoxetine inhibits the reaction [Monocrotaline results in decreased expression of PRKG1 protein] | 21619414 |
| D005557 | Formaldehyde | "8-bromoguanosino-3',5'-cyclic monophosphorothioate inhibits the reaction [Formaldehyde results in increased expression of PRKG1 protein]" | 12620371 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of PRKG1 protein | 12620371 |
| D005557 | Formaldehyde | Morphine inhibits the reaction [Formaldehyde results in increased expression of PRKG1 protein] | 12620371 |
| C069837 | fullerene C60 | fullerene C60 results in decreased expression of PRKG1 mRNA | 19167457 |
| C001277 | geldanamycin | geldanamycin results in increased expression of PRKG1 mRNA | 26705709 |
| D005947 | Glucose | acetovanillone inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | 17320767 |
| D005947 | Glucose | diphenyleneiodonium inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | 17320767 |
| D005947 | Glucose | Glucose results in decreased expression of and results in decreased activity of PRKG1 protein | 17320767 |
| D005947 | Glucose | Glucose results in decreased expression of PRKG1 mRNA | 17320767 |
| D005947 | Glucose | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | 17320767 |
| D005947 | Glucose | Reactive Oxygen Species promotes the reaction [Glucose results in decreased expression of PRKG1 protein] | 17320767 |
| D005947 | Glucose | tempol inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | 17320767 |
| D006152 | Cyclic GMP | Cyclic GMP results in increased activity of PRKG1 protein | 17616649 |
| D006152 | Cyclic GMP | Peroxynitrous Acid inhibits the reaction [Cyclic GMP results in increased activity of PRKG1 protein] | 17616649 |
| D006152 | Cyclic GMP | Cyclic GMP results in increased activity of PRKG1 protein | 18037907 |
| D006830 | Hydralazine | [Hydralazine co-treated with Valproic Acid] results in increased expression of PRKG1 mRNA | 17183730 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PRKG1 mRNA | 28628672 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRKG1 mRNA | 28628672 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRKG1 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PRKG1 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PRKG1 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PRKG1 mRNA | 28628672 |
| D007548 | Isosorbide Dinitrate | Isosorbide Dinitrate results in decreased expression of PRKG1 protein | 9366573 |
| C439304 | KMUP 1 | KMUP 1 results in increased expression of PRKG1 protein | 19962417 |
| C073601 | KT 5823 | "KT 5823 inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of RHOA protein]" | 23195829 |
| C073601 | KT 5823 | "KT 5823 inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-GMP promotes the reaction [PRKG1 protein binds to and results in increased phosphorylation of ARHGEF17 protein]]" | 23195829 |
| C031895 | lead chromate | lead chromate results in decreased expression of PRKG1 mRNA | 23584427 |
| C002385 | linsidomine | linsidomine results in decreased activity of PRKG1 protein alternative form | 21351102 |
| C002385 | linsidomine | linsidomine results in increased metabolism of PRKG1 protein alternative form | 21351102 |
| C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | 17320767 |
| D008694 | Methamphetamine | PRKG1 gene SNP affects the susceptibility to Methamphetamine | 18316681 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of PRKG1 mRNA | 28001369 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of PRKG1 mRNA" | 20188158 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in decreased expression of PRKG1 mRNA | 24810058 |
| D008799 | Mevinphos | "1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Mevinphos results in increased expression of PRKG1 protein]" | 15617736 |
| D008799 | Mevinphos | 7-nitroindazole inhibits the reaction [Mevinphos results in increased expression of PRKG1 protein] | 15617736 |
| D008799 | Mevinphos | Mevinphos results in increased expression of PRKG1 protein | 15617736 |
| D016686 | Monocrotaline | Fluoxetine inhibits the reaction [Monocrotaline results in decreased expression of PRKG1 protein] | 21619414 |
| D016686 | Monocrotaline | Monocrotaline results in decreased expression of PRKG1 protein | 21619414 |
| C517284 | monomethyl phthalate | monomethyl phthalate affects the expression of PRKG1 mRNA | 26924002 |
| D009020 | Morphine | Morphine inhibits the reaction [Formaldehyde results in increased expression of PRKG1 protein] | 12620371 |
| D009532 | Nickel | Nickel results in decreased expression of PRKG1 mRNA | 24768652|2558310 |
| D005996 | Nitroglycerin | Nitroglycerin results in decreased expression of PRKG1 protein | 11331261 |
| D005996 | Nitroglycerin | Nitroglycerin results in decreased expression of PRKG1 protein | 11331261 |
| D005996 | Nitroglycerin | Nitroglycerin affects the expression of PRKG1 mRNA | 18037907 |
| D005996 | Nitroglycerin | Nitroglycerin affects the expression of PRKG1 protein | 18037907 |
| D005996 | Nitroglycerin | Nitroglycerin results in increased activity of PRKG1 protein | 18037907 |
| D005996 | Nitroglycerin | Superoxides affects the reaction [Nitroglycerin results in increased activity of PRKG1 protein] | 18037907 |
| D009599 | Nitroprusside | Nitroprusside results in decreased expression of PRKG1 mRNA | 9366573 |
| D026423 | S-Nitroso-N-Acetylpenicillamine | S-Nitroso-N-Acetylpenicillamine results in decreased expression of PRKG1 mRNA | 9366573 |
| D026423 | S-Nitroso-N-Acetylpenicillamine | [S-Nitroso-N-Acetylpenicillamine co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | 11799084 |
| D026423 | S-Nitroso-N-Acetylpenicillamine | S-Nitroso-N-Acetylpenicillamine results in increased activity of PRKG1 protein | 11799084 |
| C572573 | N-nitroso-tris-chloroethylurea | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PRKG1 mRNA | 27935865 |
| C093285 | NOC 18 | PRKG1 protein promotes the reaction [NOC 18 results in increased expression of COL4A2 protein] | 21307347 |
| C093285 | NOC 18 | PRKG1 protein promotes the reaction [NOC 18 results in increased expression of COL4A3 mRNA] | 21307347 |
| D019319 | Okadaic Acid | "[calyculin A co-treated with Okadaic Acid] inhibits the reaction [2-methyl-1-((4-methyl-5-isoquinolinyl)sulfonyl)homopiperazine inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of ARHGEF17 protein]]" | 23195829 |
| D010100 | Oxygen | Acetylcysteine inhibits the reaction [Oxygen deficiency inhibits the reaction [8-bromocyclic GMP results in increased activity of PRKG1 protein]] | 17616649 |
| D010100 | Oxygen | Acetylcysteine inhibits the reaction [Oxygen deficiency results in decreased expression of PRKG1 protein] | 17616649 |
| D010100 | Oxygen | Oxygen deficiency inhibits the reaction [8-bromocyclic GMP results in increased activity of PRKG1 protein] | 17616649 |
| D010100 | Oxygen | Oxygen deficiency inhibits the reaction [Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of PRKG1 protein]] | 17616649 |
| D010100 | Oxygen | Oxygen deficiency results in decreased expression of PRKG1 protein | 17616649 |
| D010100 | Oxygen | Oxygen inhibits the reaction [Oxygen deficiency results in decreased expression of PRKG1 protein] | 17616649 |
| D000073878 | Palm Oil | Palm Oil results in increased expression of PRKG1 mRNA | 18042831 |
| D030421 | Peroxynitrous Acid | Peroxynitrous Acid inhibits the reaction [Cyclic GMP results in increased activity of PRKG1 protein] | 17616649 |
| D030421 | Peroxynitrous Acid | Peroxynitrous Acid results in decreased activity of PRKG1 protein | 17616649 |
| D010656 | Phenylephrine | "[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]" | 11799084 |
| D010656 | Phenylephrine | FLT1 protein promotes the reaction [Phenylephrine results in increased activity of PRKG1 protein] | 19542178 |
| D010656 | Phenylephrine | PDE1A protein promotes the reaction [Phenylephrine results in decreased activity of PRKG1 protein] | 19797176 |
| D010656 | Phenylephrine | [Phenylephrine co-treated with Copper] results in increased activity of PRKG1 protein | 26168186 |
| D010656 | Phenylephrine | Phenylephrine inhibits the reaction [Cyclosporine results in increased expression of PRKG1 mRNA] | 16378109 |
| D010656 | Phenylephrine | Phenylephrine inhibits the reaction [Cyclosporine results in increased expression of PRKG1 protein] | 16378109 |
| D010656 | Phenylephrine | Phenylephrine results in decreased activity of PRKG1 protein | 19797176 |
| D010656 | Phenylephrine | Phenylephrine results in increased activity of PRKG1 protein | 19542178|2616818 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of PRKG1 protein | 26168186 |
| D010656 | Phenylephrine | [S-Nitroso-N-Acetylpenicillamine co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | 11799084 |
| D010656 | Phenylephrine | VIM mutant form inhibits the reaction [[Copper co-treated with Phenylephrine] results in increased activity of PRKG1 protein] | 26168186 |
| D010656 | Phenylephrine | VIM mutant form inhibits the reaction [Phenylephrine results in increased activity of PRKG1 protein] | 26168186 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRKG1 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of PRKG1 mRNA | 26272509 |
| C060836 | pioglitazone | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PRKG1 mRNA | 27935865 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PRKG1 mRNA | 19710929 |
| D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls affects the expression of PRKG1 mRNA | 21334430 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species promotes the reaction [Glucose results in decreased expression of PRKG1 protein] | 17320767 |
| D000068677 | Sildenafil Citrate | PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of COL1A1 mRNA]] | 25139994 |
| D000068677 | Sildenafil Citrate | PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of CTGF mRNA]] | 25139994 |
| D000068677 | Sildenafil Citrate | PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of FN1 mRNA]] | 25139994 |
| D000068677 | Sildenafil Citrate | PRKG1 protein promotes the reaction [Sildenafil Citrate inhibits the reaction [AGT protein modified form results in increased expression of TGFB1 mRNA]] | 25139994 |
| D000068677 | Sildenafil Citrate | PRKG1 protein results in increased susceptibility to Sildenafil Citrate | 25139994 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog affects the expression of PRKG1 mRNA | 23806026 |
| C009277 | sodium arsenate | sodium arsenate results in increased expression of PRKG1 mRNA | 21795629 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of PRKG1 protein | 27774770 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of PRKG1 protein | 28918527 |
| C091861 | spermine nitric oxide complex | PRKG1 protein affects the reaction [spermine nitric oxide complex results in increased expression of IL4 protein] | 16533816 |
| C091861 | spermine nitric oxide complex | spermine nitric oxide complex results in decreased activity of PRKG1 protein alternative form | 21351102 |
| C091861 | spermine nitric oxide complex | spermine nitric oxide complex results in increased metabolism of PRKG1 protein alternative form | 21351102 |
| C091861 | spermine nitric oxide complex | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [spermine nitric oxide complex results in decreased activity of PRKG1 protein alternative form] | 21351102 |
| C091861 | spermine nitric oxide complex | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [spermine nitric oxide complex results in increased metabolism of PRKG1 protein alternative form] | 21351102 |
| D013395 | Sucrose | Sucrose results in decreased expression of PRKG1 protein | 17215582 |
| C025463 | sulindac sulfone | sulindac sulfone results in increased expression of PRKG1 protein | 11602670|1673175 |
| D013481 | Superoxides | Superoxides affects the reaction [Nitroglycerin results in increased activity of PRKG1 protein] | 18037907 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of PRKG1 mRNA | 17555576 |
| C001803 | tempol | tempol inhibits the reaction [Glucose results in decreased expression of PRKG1 protein] | 17320767 |
| C004648 | testosterone enanthate | testosterone enanthate affects the expression of PRKG1 mRNA | 17440010 |
| C004648 | testosterone enanthate | testosterone enanthate promotes the reaction [Triptorelin Pamoate results in decreased expression of PRKG1 mRNA] | 20463352 |
| C004648 | testosterone enanthate | testosterone enanthate promotes the reaction [Triptorelin Pamoate results in decreased expression of PRKG1 protein] | 20463352 |
| C004648 | testosterone enanthate | testosterone enanthate results in decreased expression of PRKG1 mRNA | 20463352|2308548 |
| C004648 | testosterone enanthate | testosterone enanthate results in decreased expression of PRKG1 protein | 20463352 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of PRKG1 mRNA | 21296121 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of PRKG1 mRNA | 21570461 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of PRKG1 mRNA | 20159946 |
| C050950 | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [spermine nitric oxide complex results in decreased activity of PRKG1 protein alternative form] | 21351102 |
| C050950 | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex | tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [spermine nitric oxide complex results in increased metabolism of PRKG1 protein alternative form] | 21351102 |
| D013792 | Thalidomide | Thalidomide results in decreased expression of PRKG1 mRNA | 26217789 |
| C012589 | trichostatin A | trichostatin A results in increased expression of PRKG1 mRNA | 27188386 |
| D017329 | Triptorelin Pamoate | testosterone enanthate promotes the reaction [Triptorelin Pamoate results in decreased expression of PRKG1 mRNA] | 20463352 |
| D017329 | Triptorelin Pamoate | testosterone enanthate promotes the reaction [Triptorelin Pamoate results in decreased expression of PRKG1 protein] | 20463352 |
| D017329 | Triptorelin Pamoate | Triptorelin Pamoate results in decreased expression of PRKG1 mRNA | 20463352 |
| D017329 | Triptorelin Pamoate | Triptorelin Pamoate results in decreased expression of PRKG1 protein | 20463352 |
| D014635 | Valproic Acid | [Hydralazine co-treated with Valproic Acid] results in increased expression of PRKG1 mRNA | 17183730 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of PRKG1 mRNA | 23179753|2718838 |
| D014639 | Vanadium | Vanadium results in decreased expression of PRKG1 mRNA | 19000753 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of PRKG1 gene | 25560391 |
| C111237 | vorinostat | vorinostat results in increased expression of PRKG1 mRNA | 27188386 |
| C108830 | Y 27632 | "Y 27632 inhibits the reaction [[8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein] results in increased activity of ARHGEF17 protein]" | 23195829 |